HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Soonmyung Paik Selected Research

Drug Therapy (Chemotherapy)

7/2023Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor-Positive Breast Cancer.
1/2023Replication of genetic associations of chemotherapy-related cardiotoxicity in the adjuvant NSABP B-31 clinical trial.
10/2020Validation of the NSABP/NRG Oncology 8-Gene Trastuzumab-benefit Signature in Alliance/NCCTG N9831.
1/2020Correction to: NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer.
1/2020Clinical Outcomes in Early Breast Cancer With a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy: A Secondary Analysis of the TAILORx Randomized Clinical Trial.
1/2020Genomic profiling of the residual disease of advanced high-grade serous ovarian cancer after neoadjuvant chemotherapy.
1/2020Destabilization of β-catenin and RAS by targeting the Wnt/β-catenin pathway as a potential treatment for triple-negative breast cancer.
12/2019Incidence of Late Relapses in Patients With HER2-Positive Breast Cancer Receiving Adjuvant Trastuzumab: Combined Analysis of NCCTG N9831 (Alliance) and NRG Oncology/NSABP B-31.
12/2019NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer.
4/2019A Therapeutic Strategy for Chemotherapy-Resistant Gastric Cancer via Destabilization of Both β-Catenin and RAS.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Soonmyung Paik Research Topics

Disease

79Breast Neoplasms (Breast Cancer)
02/2024 - 06/2002
61Neoplasms (Cancer)
07/2023 - 06/2002
10Colonic Neoplasms (Colon Cancer)
02/2024 - 03/2010
6Colorectal Neoplasms (Colorectal Cancer)
04/2019 - 10/2008
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 01/2016
4Stomach Neoplasms (Stomach Cancer)
12/2019 - 06/2017
3Pathologic Complete Response
06/2023 - 06/2008
3Triple Negative Breast Neoplasms
01/2023 - 07/2014
3Heart Failure
01/2023 - 10/2005
3Squamous Cell Carcinoma of Head and Neck
12/2020 - 02/2015
3Neoplasm Metastasis (Metastasis)
12/2019 - 10/2019
3Adenocarcinoma of Lung
01/2018 - 10/2015
3Microsatellite Instability
06/2017 - 03/2007
3Neutropenia
09/2015 - 06/2008
2Residual Neoplasm
01/2020 - 01/2020
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2018 - 11/2017
2Noninfiltrating Intraductal Carcinoma (DCIS)
09/2017 - 04/2012
1Cardiovascular Diseases (Cardiovascular Disease)
01/2023
1Cardiotoxicity
01/2023
1Ovarian Neoplasms (Ovarian Cancer)
01/2020
1Margins of Excision
12/2019
1Diarrhea
12/2019
1Back Pain (Backache)
01/2019
1Arthralgia (Joint Pain)
01/2019
1Urinary Tract Infections (Urinary Tract Infection)
01/2019
1Left Ventricular Dysfunction
01/2019
1Adenocarcinoma
10/2018
1Second Primary Neoplasms (Neoplasms, Second)
07/2018
1Carcinoma (Carcinomatosis)
11/2017
1Mesothelioma
11/2017
1Melanoma (Melanoma, Malignant)
11/2017
1Brain Neoplasms (Brain Tumor)
11/2017

Drug/Important Bio-Agent (IBA)

23Estrogen ReceptorsIBA
07/2023 - 12/2002
22TamoxifenFDA LinkGeneric
07/2023 - 10/2002
20Trastuzumab (Herceptin)FDA Link
06/2023 - 06/2002
14Biomarkers (Surrogate Marker)IBA
04/2020 - 12/2002
13Paclitaxel (Taxol)FDA LinkGeneric
06/2023 - 06/2002
12Doxorubicin (Adriamycin)FDA LinkGeneric
01/2023 - 06/2002
12ParaffinIBA
10/2021 - 12/2004
11Hormones (Hormone)IBA
02/2024 - 12/2006
11Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2019 - 06/2002
9B 31IBA
01/2023 - 06/2002
8Proteins (Proteins, Gene)FDA Link
01/2018 - 06/2002
7Oxaliplatin (Eloxatin)FDA LinkGeneric
02/2024 - 12/2012
7Formaldehyde (Formol)FDA Link
10/2021 - 05/2005
7Progesterone Receptors (Progesterone Receptor)IBA
10/2020 - 01/2010
7human ERBB2 proteinIBA
07/2018 - 01/2007
5Leucovorin (Folinic Acid)FDA Link
02/2024 - 09/2010
5Fluorouracil (Carac)FDA LinkGeneric
02/2024 - 09/2010
5AnthracyclinesIBA
01/2023 - 01/2008
5Docetaxel (Taxotere)FDA Link
07/2017 - 05/2006
4ErbB Receptors (EGF Receptor)IBA
01/2020 - 11/2015
4Messenger RNA (mRNA)IBA
10/2019 - 06/2007
4RNA (Ribonucleic Acid)IBA
01/2018 - 06/2008
4Bevacizumab (Avastin)FDA Link
01/2018 - 07/2013
4desintegron BIBA
10/2016 - 12/2004
4Estrogens (Estrogen)FDA Link
04/2012 - 01/2010
3Letrozole (Femara)FDA LinkGeneric
02/2024 - 12/2006
3Aromatase InhibitorsIBA
02/2024 - 12/2006
3Dihydrotachysterol (AT 10)IBA
07/2023 - 08/2006
3Lapatinib (GW572016)FDA Link
06/2023 - 11/2013
3DNA (Deoxyribonucleic Acid)IBA
10/2021 - 07/2013
3CateninsIBA
01/2020 - 04/2019
3GemcitabineFDA Link
09/2015 - 06/2008
3Selective Estrogen Receptor Modulators (SERM)IBA
01/2015 - 11/2011
3Raloxifene Hydrochloride (Evista)FDA Link
01/2015 - 11/2011
2Immune Checkpoint InhibitorsIBA
08/2020 - 06/2017
2neratinibIBA
01/2020 - 12/2019
2KYA1797KIBA
01/2020 - 04/2019
2taxaneIBA
01/2020 - 09/2013
2dacomitinibIBA
12/2015 - 02/2015
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
11/2015 - 12/2004
2P-2 (P 2)IBA
01/2015 - 07/2013
2Monoclonal AntibodiesIBA
10/2008 - 10/2008
12- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- oneIBA
02/2024
1Antineoplastic Agents (Antineoplastics)IBA
01/2023
1TRPC6 Cation ChannelIBA
01/2023
1Circulating Tumor DNAIBA
01/2023
1Programmed Cell Death 1 ReceptorIBA
01/2021
1NVP-BKM120IBA
12/2020
1Cetuximab (Erbitux)FDA Link
12/2020
1AntigensIBA
08/2020
1Interferon Type IIBA
08/2020
1Immune Checkpoint ProteinsIBA
01/2020
1Transcription Factors (Transcription Factor)IBA
12/2019
1IDF-11774IBA
11/2018
1Vacuolar Proton-Translocating ATPases (V-Type ATPase)IBA
11/2018
1AD 11IBA
10/2018
1Doxycycline (Periostat)FDA LinkGeneric
01/2018
1Nicotinamide PhosphoribosyltransferaseIBA
01/2018
1Hematoxylin (Haematoxylon)IBA
09/2017

Therapy/Procedure

46Therapeutics
02/2024 - 02/2003
27Drug Therapy (Chemotherapy)
07/2023 - 01/2003
16Adjuvant Chemotherapy
10/2020 - 10/2005
8Neoadjuvant Therapy
01/2023 - 06/2008
4Segmental Mastectomy (Lumpectomy)
12/2019 - 10/2002
1Critical Care (Surgical Intensive Care)
01/2023
1Mastectomy (Mammectomy)
12/2019
1Intraperitoneal Injections
01/2018
1Immunotherapy
11/2017